The Latest Breaking News from FDA

The Food and Drug Administration is removing "black box" warnings on hormone replacement therapy for menopause.

The Food and Drug Administration says it will remove a long-standing warning from hormone-based drugs used to treat menopause symptoms in women

California health officials say tests showed that ByHeart baby formula linked to a botulism outbreak contained the type of bacteria that produces the toxin that has sickened at least 13 infants in 10 states

ByHeart infant formula recalled after botulism outbreak sickens babies across 10 states, prompting urgent FDA warnings and nationwide concern among parents.

Beauty has established itself as a major commercial industry throughout history. The industry profits from our wish to appear and feel our most attractive through the sale of miracle creams and age-reversing serums. The attractive packaging of products does not always guarantee their actual performance. Many beauty scams have deceived…

FDA probes ByHeart recall after 13 infants fall ill from suspected botulism. Parents urged to stop using affected baby formula immediately.

Public health advocates praise rewrite of legislation backed by big-food influence operation AFIT

The modern food supply offers a wide range of convenient and delicious options. However, some of these foods come with a very high and a very well-documented health risk. Major global health organizations, like the World Health Organization (W.H.O.) and the American Heart Association (AHA), have issued strong warnings about…

The U.S. Food and Drug Administration (FDA) approved on Thursday Johnson Johnson’s (NYSE:JNJ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for a type of blood cancer.

When a food product is contaminated with a major pathogen like E. coli or Listeria, it will often make the national news. However, a huge number of food recalls are for more minor issues. This can include an undeclared allergen or a physical contaminant like a piece of plastic. These…

On Thursday, the U.S. Food and Drug Administration (FDA) announced six additional awardees under the Commissioner's National Priority Voucher (CNPV) pilot program.